Ramp
Secondary Market in 2025
Ramp Holdings, Inc. specializes in Software-as-a-Service solutions aimed at modernizing financial operations and enhancing content delivery. The company provides a comprehensive platform that includes tools for corporate card management, expense tracking, bill payments, and accounting integrations. By leveraging advanced technologies such as speech-to-text, natural language processing, and search engine optimization, Ramp allows organizations to maximize the value of their video content and drive increased engagement. Its offerings also include various video management solutions, notably for the SharePoint ecosystem, which facilitate seamless integration, live streaming, and efficient content delivery. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation. The company serves diverse industries, including media, finance, healthcare, and technology, with a focus on creating cost-effective and insightful financial tools for organizations.
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.
Ramp Holdings, Inc. specializes in Software-as-a-Service solutions aimed at modernizing financial operations and enhancing content delivery. The company provides a comprehensive platform that includes tools for corporate card management, expense tracking, bill payments, and accounting integrations. By leveraging advanced technologies such as speech-to-text, natural language processing, and search engine optimization, Ramp allows organizations to maximize the value of their video content and drive increased engagement. Its offerings also include various video management solutions, notably for the SharePoint ecosystem, which facilitate seamless integration, live streaming, and efficient content delivery. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation. The company serves diverse industries, including media, finance, healthcare, and technology, with a focus on creating cost-effective and insightful financial tools for organizations.
Reflex Robotics
Seed Round in 2023
Reflex Robotics specializes in developing affordable humanoid robots, priced at around $10,000, to automate hazardous and repetitive tasks in logistics and manufacturing sectors. Their robots are designed and manufactured in-house by a team that previously led the development of the Stretch robot at Boston Dynamics and key components of Tesla's Model S, X, and Y production lines. The company's robotic technology is currently employed in beverage packing, warehouse palletizing, and shelf tote picking, aiming to streamline daily operations for various industries.
Volta Labs
Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in engineering and developing innovative tools for biological automation, focusing on scalable automation solutions for genetic engineering. Its platform is designed to revolutionize genomics research by providing affordable genomic sample preparation and automation for complex biological workflows. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs aims to streamline sample processing and enhance the capabilities of biotech organizations in the next generation of genomic automation.
Scipher Medicine
Series D in 2022
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Vicarious Surgical
Post in 2021
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.
SingleStore
Series F in 2021
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.
Scipher Medicine
Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.
Vicarious Surgical
Series A in 2020
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.
Commonwealth Fusion Systems
Series A in 2020
Commonwealth Fusion Systems LLC is an energy research company based in Cambridge, Massachusetts, focused on developing fusion energy technology to address climate change. Established in 2017 as a spin-out from the Massachusetts Institute of Technology, the company utilizes rare-earth barium copper oxide superconductor technology to enhance fusion energy production. By integrating proven physics with advanced superconducting magnet technology, Commonwealth Fusion Systems aims to accelerate the commercialization of fusion energy. The company's efforts are directed toward designing and constructing fusion machines that promise limitless and clean energy, positioning them as a key player in the transition to renewable energy sources. Through collaboration with MIT's Plasma Science and Fusion Center, the company leverages decades of government-funded research to innovate within the private sector, ultimately contributing to the global pursuit of sustainable energy solutions.
E25Bio
Venture Round in 2020
E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018, that focuses on developing rapid diagnostic tests for epidemic fever viruses. The company designs paper-based diagnostic systems and kits that facilitate the detection of viruses such as dengue, chikungunya, and Zika. E25Bio's innovative platform enables multiplexed testing that quickly identifies viral antigens during infections, allowing for real-time data reporting through a mobile application. This capability supports epidemiologic predictions and disease mapping, empowering governments and health organizations to respond effectively to outbreaks and manage public health crises. Through its commitment to fast, mobile testing solutions, E25Bio aims to prevent severe health outcomes associated with viral epidemics.
Iora Health
Series F in 2020
Iora Health, Inc. is a healthcare organization based in Boston, Massachusetts, that specializes in providing primary care services across the United States. Founded in 2010, Iora Health focuses on redesigning primary care to eliminate barriers and enhance patient experience. Each patient is assigned a personal physician and a health coach, ensuring continuous support and communication through various channels, including email, text, and video, in addition to in-person visits. The company employs a team-based approach to care, which includes a doctor or nurse practitioner, a nurse, a behavioral health specialist, and a health coach, all supported by a proprietary technology platform that integrates population health management into the primary care workflow. Iora Health also offers educational programs, such as group visits, to help patients stay engaged with their health and achieve their wellness goals.
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.
Commonwealth Fusion Systems
Series A in 2019
Commonwealth Fusion Systems LLC is an energy research company based in Cambridge, Massachusetts, focused on developing fusion energy technology to address climate change. Established in 2017 as a spin-out from the Massachusetts Institute of Technology, the company utilizes rare-earth barium copper oxide superconductor technology to enhance fusion energy production. By integrating proven physics with advanced superconducting magnet technology, Commonwealth Fusion Systems aims to accelerate the commercialization of fusion energy. The company's efforts are directed toward designing and constructing fusion machines that promise limitless and clean energy, positioning them as a key player in the transition to renewable energy sources. Through collaboration with MIT's Plasma Science and Fusion Center, the company leverages decades of government-funded research to innovate within the private sector, ultimately contributing to the global pursuit of sustainable energy solutions.
Vicarious Surgical
Series B in 2019
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.
Nebula Genomics
Series A in 2018
Nebula Genomics is a biotechnology company founded in 2016 and based in San Francisco, California. It specializes in human genome sequencing and the creation of a marketplace for genomic and health data aimed at consumers, researchers, and the medical community. The company's mission is to facilitate genomic sequencing and enhance personalized medicine by aggregating a substantial repository of genetic information. Utilizing blockchain technology, Nebula Genomics ensures that consumers retain control over their data and receive compensation for its use. The marketplace enables researchers to analyze rich genetic datasets, which can accelerate drug development and improve the efficiency of clinical trials. Founded by prominent genomics researcher George Church and his associates, Nebula Genomics offers advanced DNA sequencing technology that allows clients to explore all genes and genetic variants in the genome, thereby providing comprehensive insights into individual health.
Scipher Medicine
Series A in 2018
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Digital Alloys
Series B in 2018
Digital Alloys, Inc. is a manufacturer of advanced metal 3-D printers based in Burlington, Massachusetts. Established in 2017 as a spinout from New Valence Robotics, the company specializes in high-speed, multi-metal additive manufacturing systems that enable the production of parts from a wide range of metals at significantly lower costs compared to traditional methods. Its innovative technology utilizes commodity wire as the raw material, allowing for a simpler and faster process of melting wire into complex shapes. This capability not only reduces manufacturing expenses but also empowers customers to explore new designs and create products with enhanced thermal, electrical, magnetic, and mechanical properties. Digital Alloys targets a diverse array of applications, aiming to make metal 3D printing more accessible and economical for various industries.
Ten Percent Happier
Seed Round in 2018
Ten Percent Happier, Inc. is a Boston-based company that offers a meditation platform aimed at individuals who may be skeptical about traditional meditation practices. Founded in 2013, the company provides a mobile application that facilitates learning, practicing, and tracking meditation behaviors. The platform features expert-led courses, articles, and podcasts designed to foster meaningful changes in users' lives. Additionally, Ten Percent Happier publishes books that contain practical instructions for meditation, ensuring accessibility for a diverse audience. The company focuses on delivering a clear and straightforward approach to meditation, combining various multimedia resources to engage users effectively.
Iora Health
Series E in 2018
Iora Health, Inc. is a healthcare organization based in Boston, Massachusetts, that specializes in providing primary care services across the United States. Founded in 2010, Iora Health focuses on redesigning primary care to eliminate barriers and enhance patient experience. Each patient is assigned a personal physician and a health coach, ensuring continuous support and communication through various channels, including email, text, and video, in addition to in-person visits. The company employs a team-based approach to care, which includes a doctor or nurse practitioner, a nurse, a behavioral health specialist, and a health coach, all supported by a proprietary technology platform that integrates population health management into the primary care workflow. Iora Health also offers educational programs, such as group visits, to help patients stay engaged with their health and achieve their wellness goals.
Vicarious Surgical
Series A in 2018
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.
Mainspring
Series C in 2017
Mainspring designs and develops digital business strategies. The company provides consulting services focusing on digital technologies, business optimization, and technology enablement. Mainspring, formerly known as Mainspring Communications Inc., was founded in 1996 and is based in Cambridge, Massachusetts.
Twine Health
Series A in 2017
Twine Health, Inc. is a cloud-based software platform focused on chronic care management. Founded in 2012 and based in Cambridge, Massachusetts, Twine Health provides tools for shared decision-making, enabling patients and clinicians to collaboratively set health goals and evaluate management options. Its platform includes self-tracking tools that empower patients to take control of their conditions, dashboards for clinicians to monitor patient progress, and integrated messaging features to facilitate communication. Twine Health also offers a patient engagement portal, a peer support network, and an outcome analytics tool, all designed to foster collaboration among patients, healthcare providers, and support teams such as nurses and health coaches. The platform aims to enhance patient self-efficacy and improve health outcomes through continuous, personalized care.
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.
Digital Alloys
Series A in 2017
Digital Alloys, Inc. is a manufacturer of advanced metal 3-D printers based in Burlington, Massachusetts. Established in 2017 as a spinout from New Valence Robotics, the company specializes in high-speed, multi-metal additive manufacturing systems that enable the production of parts from a wide range of metals at significantly lower costs compared to traditional methods. Its innovative technology utilizes commodity wire as the raw material, allowing for a simpler and faster process of melting wire into complex shapes. This capability not only reduces manufacturing expenses but also empowers customers to explore new designs and create products with enhanced thermal, electrical, magnetic, and mechanical properties. Digital Alloys targets a diverse array of applications, aiming to make metal 3D printing more accessible and economical for various industries.
Vicarious Surgical
Venture Round in 2016
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.
Iora Health
Series D in 2016
Iora Health, Inc. is a healthcare organization based in Boston, Massachusetts, that specializes in providing primary care services across the United States. Founded in 2010, Iora Health focuses on redesigning primary care to eliminate barriers and enhance patient experience. Each patient is assigned a personal physician and a health coach, ensuring continuous support and communication through various channels, including email, text, and video, in addition to in-person visits. The company employs a team-based approach to care, which includes a doctor or nurse practitioner, a nurse, a behavioral health specialist, and a health coach, all supported by a proprietary technology platform that integrates population health management into the primary care workflow. Iora Health also offers educational programs, such as group visits, to help patients stay engaged with their health and achieve their wellness goals.
SingleStore
Series C in 2016
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.
Twine Health
Series A in 2015
Twine Health, Inc. is a cloud-based software platform focused on chronic care management. Founded in 2012 and based in Cambridge, Massachusetts, Twine Health provides tools for shared decision-making, enabling patients and clinicians to collaboratively set health goals and evaluate management options. Its platform includes self-tracking tools that empower patients to take control of their conditions, dashboards for clinicians to monitor patient progress, and integrated messaging features to facilitate communication. Twine Health also offers a patient engagement portal, a peer support network, and an outcome analytics tool, all designed to foster collaboration among patients, healthcare providers, and support teams such as nurses and health coaches. The platform aims to enhance patient self-efficacy and improve health outcomes through continuous, personalized care.
Editas Medicine
Series B in 2015
Editas Medicine is a clinical-stage biotechnology company based in Cambridge, Massachusetts, with an additional site in Boulder, Colorado. Founded in 2013, the company focuses on the discovery and development of genome editing therapeutics, primarily utilizing its proprietary CRISPR/Cas9 technology. This innovative platform enables precise molecular modifications at the genetic level, with the aim of treating a wide array of serious diseases by addressing their underlying causes. Editas Medicine has established a strong intellectual property portfolio, which includes numerous patents related to foundational genome editing technologies and advancements that facilitate the translation of research into viable human therapeutics. The company's mission is to pioneer transformative genomic medicines that can significantly improve patient outcomes across various genetic disorders.
SolidEnergy Systems Corp. develops and manufactures rechargeable lithium metal batteries primarily for applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and based in Woburn, Massachusetts, the company focuses on producing high-performance lithium metal batteries and supplying essential materials, such as anodes and electrolytes, to major lithium-ion cell manufacturers. These materials can be integrated into existing manufacturing processes, allowing for scalability without significant infrastructure investments. SolidEnergy's pilot-scale production caters to prototype demonstrations and specialized aerospace markets, while its future growth is aimed at mainstream sectors like consumer electronics and electric vehicles. Additionally, the company is involved in developing AI-powered safety algorithms and recycling solutions, positioning itself as an integrated battery manufacturer with a commitment to innovation and sustainability.
Iora Health
Series C in 2015
Iora Health, Inc. is a healthcare organization based in Boston, Massachusetts, that specializes in providing primary care services across the United States. Founded in 2010, Iora Health focuses on redesigning primary care to eliminate barriers and enhance patient experience. Each patient is assigned a personal physician and a health coach, ensuring continuous support and communication through various channels, including email, text, and video, in addition to in-person visits. The company employs a team-based approach to care, which includes a doctor or nurse practitioner, a nurse, a behavioral health specialist, and a health coach, all supported by a proprietary technology platform that integrates population health management into the primary care workflow. Iora Health also offers educational programs, such as group visits, to help patients stay engaged with their health and achieve their wellness goals.
Quantopian
Series B in 2014
Quantopian, Inc. is an online platform that facilitates the development and testing of quantitative trading algorithms. Established in 2011 and based in Boston, Massachusetts, the company offers a comprehensive suite of tools and infrastructure that enables users to learn about quantitative finance, engage in community discussions, and explore algorithms created by other members. The platform allows users to create and backtest their own algorithms, analyze results, and evaluate risk metrics. Quantopian also fosters an engaged community of approximately 195,000 quants, who share insights and learn from each other. The company provides capital for algorithm authors to trade, both through monthly contests and a selection process aimed at high-quality strategies. By combining education, data, and a collaborative research environment, Quantopian inspires individuals worldwide to innovate in algorithmic investing.
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.
EyeNetra, Inc. is a company that specializes in developing and manufacturing eye diagnostic tools, including auto-refractors and lens-meters. Founded in 2011 and based in Somerville, Massachusetts, EyeNetra's innovative platform allows users to conduct their own eye tests and obtain refractive measurements for conditions such as nearsightedness, farsightedness, and astigmatism. The company’s products enable eye care professionals to administer efficient eye tests, facilitating quick and accurate diagnoses and prescriptions. Among its offerings is the NETRA autorefractor, which, along with other devices, provides a comprehensive refraction system designed for ease of use and high precision. Additionally, EyeNetra has developed the Insight Portal, enhancing electronic medical record capabilities and providing a streamlined solution for managing patients in mobile clinics globally.
Ambri, Inc., established in 2010 and headquartered in Marlborough, Massachusetts, specializes in developing electricity storage solutions for electric grids. The company is renowned for its liquid metal battery cell technology, designed to be low-cost, long-lasting, and capable of storing large amounts of energy. Ambri's batteries are intended for use in renewable energy systems, grid stabilization, and other large-scale applications where reliable and efficient energy storage is crucial.
SingleStore
Series B in 2014
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.
Quantopian
Series A in 2013
Quantopian, Inc. is an online platform that facilitates the development and testing of quantitative trading algorithms. Established in 2011 and based in Boston, Massachusetts, the company offers a comprehensive suite of tools and infrastructure that enables users to learn about quantitative finance, engage in community discussions, and explore algorithms created by other members. The platform allows users to create and backtest their own algorithms, analyze results, and evaluate risk metrics. Quantopian also fosters an engaged community of approximately 195,000 quants, who share insights and learn from each other. The company provides capital for algorithm authors to trade, both through monthly contests and a selection process aimed at high-quality strategies. By combining education, data, and a collaborative research environment, Quantopian inspires individuals worldwide to innovate in algorithmic investing.
GreenLight Biosciences
Series A in 2013
GreenLight Biosciences, Inc. is a biotechnology company headquartered in Medford, Massachusetts, with an additional location in North Carolina. Founded in 2008, the company specializes in developing RNA-based solutions for agricultural and pharmaceutical purposes. It offers a proprietary technology platform that enables the efficient and cost-effective production of high-quality RNA, facilitating advancements in vaccine development, pandemic response, crop management, and the protection of pollinators. GreenLight develops mRNA-based vaccine candidates, including those aimed at preventing SARS-CoV-2 infections, and engages in collaborative efforts with industry leaders to further enhance its offerings. Through its innovative approach, GreenLight aims to contribute significantly to sustainable global development and food security.
Fuze, an 8x8 company
Series A in 2012
Fuze Digital Solutions, LLC is a provider of a cloud-based unified communications platform that enhances productivity and collaboration within enterprises. The platform, known as Fuze Suite, offers various features including business voice communications, video conferencing, and a suite of tools for customer care and engagement. These tools encompass a community knowledge base, case management, chat, feedback management, and online reporting, all designed to foster customer loyalty through effective communication. Founded in 2002 and originally known as ThinkingPhones, Fuze serves a diverse clientele, including organizations like Careerbuilder.com and Oregon Health & Sciences University. The company is headquartered in Boston, Massachusetts, with additional offices in major cities across North America and Europe, positioning itself as a key player in the unified communications market.
Ambri, Inc., established in 2010 and headquartered in Marlborough, Massachusetts, specializes in developing electricity storage solutions for electric grids. The company is renowned for its liquid metal battery cell technology, designed to be low-cost, long-lasting, and capable of storing large amounts of energy. Ambri's batteries are intended for use in renewable energy systems, grid stabilization, and other large-scale applications where reliable and efficient energy storage is crucial.
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.
Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. Founded in 2005 and headquartered in San Francisco, California, with additional offices in major cities worldwide, Lookout offers a range of products including mobile security apps for both Android and iOS devices. Its solutions encompass Mobile Threat Protection, a Mobile Intelligence Center for real-time threat investigations, and an App Vetting API designed to secure enterprise and commercial app stores. By providing organizations with tools to enable bring-your-own-device (BYOD) policies, ensure compliance, and combat advanced mobile threats, Lookout empowers enterprises and individuals to safeguard their sensitive data across devices, applications, networks, and clouds. The company's platform is trusted by various enterprises, government agencies, and millions of consumers, allowing them to manage their data securely and efficiently.
Lumenz
Venture Round in 2008
LumenZ, Inc is a Boston-based opto-electronic and efficient LED company. If you have any further information about this company, please build out the profile by clicking [here](/organization/lumenz-in/edit_overview).